Retinalamin
Retinalamin (Retinal Peptide Bioregulator)
A peptide bioregulator derived from retinal tissue. Part of the Russian peptide bioregulator series. Used for retinal protection and vision support.
Mechanism of Action
Retinalamin modulates gene expression in retinal cells, supporting photoreceptor survival, reducing retinal oxidative stress, and promoting retinal cell function. Used clinically in Russia for retinal dystrophies.
Health Claims & Evidence
Supports retinal health and photoreceptor function
May slow retinal dystrophy progression
Reduces retinal oxidative stress
Short-Term Effects
Potential improvements in visual acuity and retinal function.
Long-Term Effects
Theoretical retinal protection with repeated courses.
Side Effects
Well-tolerated. Parabulbar injection requires medical administration.
Contraindications
Parabulbar injection requires medical supervision.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
Retinalamin in retinal dystrophy
Khavinson et al. · Bulletin of Experimental Biology and Medicine · 2004
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on Retinalamin and related peptides, and prepare an educational research summary.
Explore Research